Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe F Lau

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Mount Sinai Journal of Medicine, New York|May 30, 2002
Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responsesJoe F Lau, Curt M Horvath
Endocrinology and Metabolism Clinics of North America|February 17, 2009
Advanced lipoprotein testing: recommendations based on current evidenceJoe F Lau, Donald A Smith
Vascular Medicine (London, England)|June 10, 2016
The vascular laboratoryYonathan Litwok, Michael Weinreich, Joe F Lau
Vascular Medicine (London, England)|April 10, 2023
Chronic thromboembolic pulmonary hypertension and the post-pulmonary embolism (PE) syndromeEugene Yuriditsky, James M Horowitz, Joe F Lau
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 10, 2015
The fluoro-less and contrast-less peripheral endovascular intervention: a concept for the future todayGeorges Ephrem, Joe F Lau, Perwaiz M Meraj
Nature Reviews. Cardiology|May 22, 2013
Oral anticoagulants in the management of venous thromboembolismJohn N Makaryus, Jonathan L Halperin, Joe F Lau
Emergency Radiology|November 7, 2020
Thromboembolic complications of COVID-19Leonora W Mui, Joe F Lau, Hwayoung K Lee
Nature Reviews. Cardiology|June 2, 2011
Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosisJoe F Lau, Mitchell D Weinberg, Jeffrey W Olin
Journal of Virology|June 7, 2002
STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replicationJean-Patrick Parisien, Joe F Lau, Curt M Horvath
Vascular Medicine (London, England)|February 21, 2017
Advanced vascular imagingMichael Weinreich, Yonathan Litwok, Leonora W Mui, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Mount Sinai Journal of Medicine, New York|May 30, 2002
Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responsesJoe F Lau, Curt M Horvath
Endocrinology and Metabolism Clinics of North America|February 17, 2009
Advanced lipoprotein testing: recommendations based on current evidenceJoe F Lau, Donald A Smith
Vascular Medicine (London, England)|June 10, 2016
The vascular laboratoryYonathan Litwok, Michael Weinreich, Joe F Lau
Vascular Medicine (London, England)|April 10, 2023
Chronic thromboembolic pulmonary hypertension and the post-pulmonary embolism (PE) syndromeEugene Yuriditsky, James M Horowitz, Joe F Lau
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 10, 2015
The fluoro-less and contrast-less peripheral endovascular intervention: a concept for the future todayGeorges Ephrem, Joe F Lau, Perwaiz M Meraj
Nature Reviews. Cardiology|May 22, 2013
Oral anticoagulants in the management of venous thromboembolismJohn N Makaryus, Jonathan L Halperin, Joe F Lau
Emergency Radiology|November 7, 2020
Thromboembolic complications of COVID-19Leonora W Mui, Joe F Lau, Hwayoung K Lee
Nature Reviews. Cardiology|June 2, 2011
Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosisJoe F Lau, Mitchell D Weinberg, Jeffrey W Olin
Journal of Virology|June 7, 2002
STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replicationJean-Patrick Parisien, Joe F Lau, Curt M Horvath
Vascular Medicine (London, England)|February 21, 2017
Advanced vascular imagingMichael Weinreich, Yonathan Litwok, Leonora W Mui, et al.
Pageof 3